Assessing the Dynamic Market for Biologics

April 15, 2021 PAO-04-22-R221-23

In a Copenhagen, Denmark stop on the Road to 2021, Morten Munk, Director of Global Alliance Management at FUJIFILM Diosynth Biotechnologies, discusses the dynamics of the biologics market and trends in the use of single-use versus stainless steel technology.

 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

FUJIFILM Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies is a biologics contract manufacturing organization with locations in Research Triangle Park, North Carolina, Texas, USA and Billingham, UK. The company has experience in the development and manufacture of recombinant proteins, vaccines and monoclonal antibodies, expressed in a wide array of microbial, mammalian, and insect cell systems. Fujifilm Diosynth Biotechnologies offers a list of services from cell line development using its proprietary system to process development, analytical development, clinical and commercial manufacturing.

Q: